These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 28895035)
21. Study on responses after splenectomy for idiopathic thrombocytopenic purpura patients, Kathmandu, Nepal. Shrestha S; Pradhan GB; Shrestha R; Singh R Nepal Med Coll J; 2012 Dec; 14(4):328-30. PubMed ID: 24579545 [TBL] [Abstract][Full Text] [Related]
22. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360 [TBL] [Abstract][Full Text] [Related]
24. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura. Pasa S; Altintas A; Cil T; Danis R; Ayyildiz O J Thromb Thrombolysis; 2009 Apr; 27(3):329-33. PubMed ID: 18311541 [TBL] [Abstract][Full Text] [Related]
25. Platelet count evolution as a predictor of outcome after splenectomy for immune thrombocytopenic purpura. Kim M; Park KM; Shin WY; Choe YM; Lee KY; Ahn SI Int J Hematol; 2017 Apr; 105(4):433-439. PubMed ID: 27787747 [TBL] [Abstract][Full Text] [Related]
26. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis. Auger S; Duny Y; Rossi JF; Quittet P Br J Haematol; 2012 Aug; 158(3):386-98. PubMed ID: 22612239 [TBL] [Abstract][Full Text] [Related]
27. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Kumar S; Diehn FE; Gertz MA; Tefferi A Ann Hematol; 2002 Jun; 81(6):312-9. PubMed ID: 12107560 [TBL] [Abstract][Full Text] [Related]
28. Are the favorable outcomes of splenectomy predictable inpatients with idiopathic thrombocytopenic purpura (ITP)? Tsereteli Z; Smith CD; Branum GD; Galloway JR; Amerson RJ; Chakaraborty H; Hunter JG Surg Endosc; 2001 Dec; 15(12):1386-9. PubMed ID: 11965451 [TBL] [Abstract][Full Text] [Related]
29. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review. Gibson M; Sehon JK; White S; Zibari GB; Johnson LW Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623 [TBL] [Abstract][Full Text] [Related]
30. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone. Oved JH; Lee CSY; Bussel JB J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312 [TBL] [Abstract][Full Text] [Related]
31. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity. Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Derumeaux H; Adoue D Am J Hematol; 2014 Jan; 89(1):41-6. PubMed ID: 24038066 [TBL] [Abstract][Full Text] [Related]
32. Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center. Ismet A; Irfan K; Emin K; AlI EM; Ramazan U; Mustafa B; Onur O Clin Lab Haematol; 2004 Jun; 26(3):211-4. PubMed ID: 15163320 [TBL] [Abstract][Full Text] [Related]
33. Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura. Katkhouda N; Grant SW; Mavor E; Friedlander MH; Lord RV; Achanta K; Essani R; Mason R Surg Endosc; 2001 May; 15(5):484-8. PubMed ID: 11353966 [TBL] [Abstract][Full Text] [Related]
34. Better outcome of splenectomy in younger patients suffering from chronic immune thrombocytopenia (ITP). Saqib S; Sultan R; Zafar H J Pak Med Assoc; 2016 Oct; 66(Suppl 3)(10):S62-S64. PubMed ID: 27895357 [TBL] [Abstract][Full Text] [Related]
35. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Shanafelt TD; Madueme HL; Wolf RC; Tefferi A Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692 [TBL] [Abstract][Full Text] [Related]
36. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura? Cooper N; Evangelista ML; Amadori S; Stasi R Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569 [TBL] [Abstract][Full Text] [Related]
37. Immune Thrombocytopenic Purpura Splenectomy in the Context of New Medical Therapies. Worrest T; Cunningham A; Dewey E; Deloughery TG; Gilbert E; Sheppard BC; Fischer LE J Surg Res; 2020 Jan; 245():643-648. PubMed ID: 31536907 [TBL] [Abstract][Full Text] [Related]
38. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years. Palandri F; Polverelli N; Sollazzo D; Romano M; Catani L; Cavo M; Vianelli N Am J Hematol; 2016 Jun; 91(4):E267-72. PubMed ID: 26799593 [TBL] [Abstract][Full Text] [Related]
39. Role of splenectomy for immune thrombocytopenic purpura (ITP) in the era of new second-line therapies and in the setting of a high prevalence of HIV-associated ITP. Antel KR; Panieri E; Novitzky N S Afr Med J; 2015 Apr; 105(5):408-12. PubMed ID: 26242673 [TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP). Gómez-Almaguer D Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]